Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2019 1
2023 1
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Optimizing Nutritional Care with Machine Learning: Identifying Sarcopenia Risk Through Body Composition Parameters in Cancer Patients-Insights from the NUTritional and Sarcopenia RIsk SCREENing Project (NUTRISCREEN).
Porciello G, Di Lauro T, Luongo A, Coluccia S, Prete M, Abbadessa L, Coppola E, Di Martino A, Mozzillo AL, Racca E, Piccirillo A, Di Giacomo V, Fontana M, D'Amico M, Palumbo E, Vitale S, D'Errico D, Turrà V, Parascandolo I, Stallone T, Augustin LSA, Crispo A, Celentano E, Pignata S. Porciello G, et al. Among authors: di lauro t. Nutrients. 2025 Apr 18;17(8):1376. doi: 10.3390/nu17081376. Nutrients. 2025. PMID: 40284239 Free PMC article.
Multicentric, observational, longitudinal study for the evaluation of nutritional management implications in newly diagnosed Italian cancer patients: the Italian Registry of Malnutrition in Oncology (IRMO).
Bosetti C, Casirati A, Da Prat V, Masi S, Crotti S, Ferrari A, Perrone L, Serra F, Santucci C, Cereda E, Iannelli E, De Lorenzo F, Pedrazzoli P, Caccialanza R; IRMO collaborators. Bosetti C, et al. BMJ Open. 2023 Aug 21;13(8):e071858. doi: 10.1136/bmjopen-2023-071858. BMJ Open. 2023. PMID: 37604631 Free PMC article.
Tumour-infiltrating leucocytes as prognostic biomarkers of bevacizumab-treated ovarian cancer patients results from the phase IV MITO16A/MaNGO OV-2 clinical trial.
Pivetta E, Canzonieri V, Bagnoli M, Chiodini P, Spina A, Arenare L, Lorusso D, Tasca G, Cecere SC, Ferrero A, Scognamiglio G, Basso-Valentina F, Califano D, De Cecco L, Di Lauro T, Nicoloso MS, Arcieri M, Russo D, Spessotto P, Indraccolo S, Mezzanzanica D, Perrone F, Pignata S, Baldassarre G. Pivetta E, et al. Among authors: di lauro t. NPJ Precis Oncol. 2025 Nov 17;9(1):355. doi: 10.1038/s41698-025-01146-7. NPJ Precis Oncol. 2025. PMID: 41249601 Free PMC article.
The impact of body mass index on survival and surgical outcomes in ovarian cancer: insights from the MITO trials.
Di Lauro T, De Benedictis I, Chiodini P, Perrone F, Arenare L, Raspagliesi F, Cecere SC, Palaia I, Carbone V, Di Stefano MG, Bianco R, Pisano C, Bartoletti M, Savarese A, Schettino C, Limongello D, Mormile MG, Coppola E, Pignata S. Di Lauro T, et al. Int J Gynecol Cancer. 2025 Nov 1:102764. doi: 10.1016/j.ijgc.2025.102764. Online ahead of print. Int J Gynecol Cancer. 2025. PMID: 41309411